Mohabbati Vahid, Mohabbati Parsa, Papan Mohammadkazem
Sydney Pain Research Centre, Sydney, NSW, Australia.
Sydney Pain Management Centre, Sydney, NSW, Australia.
Pain Med Case Rep. 2024 Jul;8(5):185-190.
Small-fiber neuropathies (SFNs), affecting thinly myelinated Ad fibers and unmyelinated C fibers, often manifest with sensory or autonomic symptoms in varied patterns. Diagnostic tools comprise skin biopsy, quantitative sensory, autonomic testing, and biochemical markers. Spinal cord stimulation (SCS), particularly high-frequency SCS, has emerged as a pivotal therapeutic intervention. CASE REPORT: This study delves into a 49-year-old woman diagnosed with idiopathic asymmetrical SF peripheral neuropathy, examining her 12-month postoperative trajectory after SCS implantation. Postsurgical assessment revealed substantial improvements: baseline pain (Numeric Rating Scale 7) decreased to 4 at 3 months, indicating reduced intensity; Oswestry Disability Index improved from 38% to 4%, highlighting enhanced functionality; Patient-Specific Questionnaire 3 average score dropped from 35 to 2, indicating improved outcomes in specific pain-related concerns. CONCLUSIONS: This case report underscores the efficacy of SCS in managing idiopathic asymmetrical SFN, demonstrating significant symptomatic relief over a 12-month postoperative period.
小纤维神经病变(SFN)会影响薄髓鞘Aδ纤维和无髓鞘C纤维,常以多种模式表现出感觉或自主神经症状。诊断工具包括皮肤活检、定量感觉测试、自主神经测试和生化标志物。脊髓刺激(SCS),尤其是高频SCS,已成为一种关键的治疗干预手段。病例报告:本研究深入探讨了一名49岁被诊断为特发性不对称性SF周围神经病变的女性,检查了她在植入SCS后的12个月术后病程。术后评估显示有显著改善:基线疼痛(数字评分量表为7)在3个月时降至4,表明疼痛强度降低;奥斯维斯特里残疾指数从38%提高到4%,突出了功能的增强;患者特定问卷3的平均得分从35降至2,表明在特定疼痛相关问题上结果有所改善。结论:本病例报告强调了SCS在治疗特发性不对称性SFN方面的疗效,显示出术后12个月内有显著的症状缓解。